MacroGenics | MGNX - Fremdkapital

Aktienkurs
2.87
Täglich Wechseln
-0.03 -1.03%
Monatlich
64.00%
Jährlich
43.86%
Q1 Prognose
2.91




Fremdkapital Veränderung Datum
AbbVie USD 62.97B 12M 2025-09
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Biogen USD 6.29B 1.4M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Genmab DKK 5.14B 5.01B 2025-12
Geron USD 119.55M 283K 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
J&J USD 39.44B 30M 2025-12
Karyopharm Therapeutics USD -0.93 0.67 2024-12
MacroGenics USD 70M 256K 2025-12
Merck USD 39.97B 6B 2025-09
Pfizer USD 57.41B 93M 2025-09
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Xencor USD 76.48M 11.29M 2025-12